Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition.

Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, Sabbagh MN, Belden CM, Caselli RJ, Adler CH, Woodruff BK, Rapscak SZ, Ahern GL, Burke AD, Jacobson S, Shill HA, Driver-Dunckley E, Chen K, Reiman EM, Beach TG, Serrano GE.

J Neuropathol Exp Neurol. 2016 Jun 12. pii: nlw047. [Epub ahead of print]

PMID:
27297671
2.

Graph theory network function in Parkinson's disease assessed with electroencephalography.

Utianski RL, Caviness JN, van Straaten EC, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH, Hentz JG.

Clin Neurophysiol. 2016 May;127(5):2228-36. doi: 10.1016/j.clinph.2016.02.017. Epub 2016 Mar 4.

PMID:
27072094
3.

Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease.

Caviness JN, Lue LF, Hentz JG, Schmitz CT, Adler CH, Shill HA, Sabbagh MN, Beach TG, Walker DG.

Mov Disord. 2016 Jul;31(7):1012-9. doi: 10.1002/mds.26621. Epub 2016 Apr 8.

PMID:
27062301
4.

Lewy bodies are incidental in essential tremor.

Shill HA, Adler CH, Beach TG.

Parkinsonism Relat Disord. 2016 May;26:81. doi: 10.1016/j.parkreldis.2016.02.025. Epub 2016 Mar 3. No abstract available.

PMID:
27010072
5.

Converging mediators from immune and trophic pathways to identify Parkinson disease dementia.

Lue LF, Schmitz CT, Snyder NL, Chen K, Walker DG, Davis KJ, Belden C, Caviness JN, Driver-Dunckley E, Adler CH, Sabbagh MN, Shill HA.

Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(1):e193. doi: 10.1212/NXI.0000000000000193. eCollection 2016 Feb.

6.

Simplified conversion method for unified Parkinson's disease rating scale motor examinations.

Hentz JG, Mehta SH, Shill HA, Driver-Dunckley E, Beach TG, Adler CH.

Mov Disord. 2015 Dec;30(14):1967-70. doi: 10.1002/mds.26435. Epub 2015 Nov 17.

PMID:
26779608
7.

Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Beach TG, Adler CH, Serrano G, Sue LI, Walker DG, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Intorcia A, Filon J, Scott S, Garcia A, Hoffman B, Belden CM, Davis KJ, Sabbagh MN; Arizona Parkinson’s Disease Consortium.

J Parkinsons Dis. 2016;6(1):153-63. doi: 10.3233/JPD-150680.

PMID:
26756744
8.

Lewy bodies in essential tremor are no different than in controls.

Shill HA, Adler CH, Beach TG.

Parkinsonism Relat Disord. 2016 Feb;23:106-7. doi: 10.1016/j.parkreldis.2015.11.025. Epub 2015 Nov 24. No abstract available.

PMID:
26644293
9.

Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts.

Caviness JN, Utianski RL, Hentz JG, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH.

Eur J Neurol. 2016 Feb;23(2):387-92. doi: 10.1111/ene.12878. Epub 2015 Oct 31.

PMID:
26518336
10.

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.

Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN.

BMC Neurol. 2015 Aug 20;15:146. doi: 10.1186/s12883-015-0403-4.

11.

REM sleep behavior disorder and neuropathology in Parkinson's disease.

Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG.

Mov Disord. 2015 Sep;30(10):1413-7. doi: 10.1002/mds.26347. Epub 2015 Aug 12.

PMID:
26265105
12.

Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease Patients.

Mu L, Chen J, Sobotka S, Nyirenda T, Benson B, Gupta F, Sanders I, Adler CH, Caviness JN, Shill HA, Sabbagh M, Samanta JE, Sue LI, Beach TG; Arizona Parkinson's Disease Consortium.

Dysphagia. 2015 Aug;30(4):404-17. doi: 10.1007/s00455-015-9612-7. Epub 2015 Jun 4.

13.

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Burke AD, Reiman EM, Sabbagh MN.

Neuropathology. 2015 Aug;35(4):354-89. doi: 10.1111/neup.12189. Epub 2015 Jan 26.

14.

Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease.

Caviness JN, Hentz JG, Belden CM, Shill HA, Driver-Dunckley ED, Sabbagh MN, Powell JJ, Adler CH.

J Parkinsons Dis. 2015;5(1):117-24. doi: 10.3233/JPD-140480.

PMID:
25420672
15.

Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease.

Driver-Dunckley E, Adler CH, Hentz JG, Dugger BN, Shill HA, Caviness JN, Sabbagh MN, Beach TG; Arizona Parkinson Disease Consortium.

Parkinsonism Relat Disord. 2014 Nov;20(11):1260-2. doi: 10.1016/j.parkreldis.2014.08.006. Epub 2014 Aug 16.

16.

Reply: Purkinje cell loss in essential tremor.

Shill HA, Adler CH, Hentz JG.

Mov Disord. 2014 Sep;29(10):1330-1. doi: 10.1002/mds.25954. Epub 2014 Aug 1. No abstract available.

PMID:
25087570
17.

Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.

Jacobson SA, Morshed T, Dugger BN, Beach TG, Hentz JG, Adler CH, Shill HA, Sabbagh MN, Belden CM, Sue LI, Caviness JN, Hu C; Arizona Parkinson's Disease Consortium.

Parkinsonism Relat Disord. 2014 Sep;20(9):1009-14. doi: 10.1016/j.parkreldis.2014.06.018. Epub 2014 Jun 28.

18.

Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study.

Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Sue LI, Jacobson SA, Belden CM, Dugger BN.

Neurology. 2014 Jul 29;83(5):406-12. doi: 10.1212/WNL.0000000000000641. Epub 2014 Jun 27.

19.

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.

Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N; Arizona Parkinson's Disease Consortium.

Neurosci Lett. 2014 Jun 13;571:34-8. doi: 10.1016/j.neulet.2014.04.027. Epub 2014 Apr 28.

20.

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.

Siderowf A, Pontecorvo MJ, Shill HA, Mintun MA, Arora A, Joshi AD, Lu M, Adler CH, Galasko D, Liebsack C, Skovronsky DM, Sabbagh MN.

BMC Neurol. 2014 Apr 9;14:79. doi: 10.1186/1471-2377-14-79.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk